Premium
WE‐AB‐202‐01: Evaluating the Toxicity Reduction with CT‐Ventilation Functional Avoidance Radiation Therapy
Author(s) -
Vinogradskiy Y,
Miyasaka Y,
Kadoya N,
Castillo R,
Castillo E,
Guerrero T,
Yamamoto T
Publication year - 2016
Publication title -
medical physics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 180
eISSN - 2473-4209
pISSN - 0094-2405
DOI - 10.1118/1.4957742
Subject(s) - medicine , functional imaging , radiation therapy , pneumonitis , ventilation (architecture) , radiation treatment planning , radiology , nuclear medicine , lung , mechanical engineering , engineering
Purpose: CT‐ventilation is an exciting new imaging modality that uses 4DCTs to calculate lung ventilation. Studies have proposed to use 4DCT‐ventilation imaging for functional avoidance radiotherapy which implies designing treatment plans to spare functional portions of the lung. Although retrospective studies have been performed to evaluate the dosimetric gains to functional lung; no work has been done to translate the dosimetric gains to an improvement in pulmonary toxicity. The purpose of our work was to evaluate the potential reduction in toxicity for 4DCT‐ventilation based functional avoidance. Methods: 70 lung cancer patients with 4DCT imaging were used for the study. CT‐ventilation maps were calculated using the patient's 4DCT, deformable image registrations, and a density‐change‐based algorithm. Radiation pneumonitis was graded using imaging and clinical information. Log‐likelihood methods were used to fit a normal‐tissue‐complication‐probability (NTCP) model predicting grade 2+ radiation pneumonitis as a function of doses (mean and V20) to functional lung (>15% ventilation). For 20 patients a functional plan was generated that reduced dose to functional lung while meeting RTOG 0617‐based constraints. The NTCP model was applied to the functional plan to determine the reduction in toxicity with functional planning Results: The mean dose to functional lung was 16.8 and 17.7 Gy with the functional and clinical plans respectively. The corresponding grade 2+ pneumonitis probability was 26.9% with the clinically‐used plan and 24.6% with the functional plan (8.5% reduction). The V20‐based grade 2+ pneumonitis probability was 23.7% with the clinically‐used plan and reduced to 19.6% with the functional plan (20.9% reduction). Conclusion: Our results revealed a reduction of 9–20% in complication probability with functional planning. To our knowledge this is the first study to apply complication probability to convert dosimetric results to toxicity improvement. The results presented in the current work provide seminal data for prospective clinical trials in functional avoidance. YV discloses funding from State of Colorado. TY discloses National Lung Cancer Partnership; Young Investigator Research grant